TAK - Codexis to sell Pompe Fabry assets to Crosswalk Therapeutics July, 01 2024 05:28 PM Takeda Pharmaceutical Company Limited American Depositary Shares 2024-07-01 17:28:05 ET More on Codexis Codexis, Inc. (CDXS) Q1 2024 Earnings Call Transcript Codexis, Inc. 2024 Q1 - Results - Earnings Call Presentation Codexis GAAP EPS of -$0.16 beats by $0.02, revenue of $17.1M beats by $3.8M Codexis Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Codexis For further details see: Codexis to sell Pompe, Fabry assets to Crosswalk Therapeutics